This page includes the latest FDA filings for Oak Pharmaceuticals Inc Subsidiary Of Akorn Inc 968937719. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.
Device Company | Device | Date |
---|---|---|
Akorn, Akorn Operating Company LLC, Akorn AG | Prescription Medication | 2022-05-03 |
Akorn, Akorn Operating Company LLC, Akorn AG | Prescription Medication | 2020-10-21 |
Akorn, Akorn Operating Company LLC, Akorn AG | Prescription Medication | 2020-10-20 |
Akorn, Akorn Operating Company LLC, Akorn AG | Prescription Medication | 2017-12-12 |
Oak Pharmaceuticals, Inc. (Subsidiary of Akorn, Inc.) (968937719) | Betimol | 2014-01-02 |
Oak Pharmaceuticals, Inc. (Subsidiary of Akorn, Inc.) (968937719) | Betimol | 2014-01-02 |